80 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
16 Apr 24
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
4:20pm
cash and investments to support planned operations into at least 2026.
R&D expenses for the year ended December 31, 2023, totaled $51.9 million
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Feb 24
Current report (foreign)
4:50pm
-management treatments. Earlier in his career, he held senior roles in business development, sales, marketing, and R&D with Tularik Inc. (acquired
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
Attention: Leo Mao/Jeff Jiang
Telephone: 0512-53577866
E-mail: qxpan@connectpharm.com/
fjiang@connectpharm.com
4th Floor, East R&D Building, Science
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
as of December 31, 2022. The decrease was mainly due to ongoing research and development (R&D) costs associated with the Company’s clinical drug programs … and investments to support planned operations into at least 2026, including funding of all clinical and regulatory milestones discussed above.
R&D expenses
6-K
k2ioij2
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
6-K
EX-99.1
mpy uup754
23 Jun 23
House Lease Contract
4:31pm
6-K
eb6fc7zg0jbajgeq01
23 Jun 23
House Lease Contract
4:31pm
6-K
EX-99.1
ibljvn p99
5 Jun 23
Current report (foreign)
4:28pm
6-K
EX-99.1
e0kdjt 4j9svwr
11 Apr 23
Connect Biopharma Reports Full Year 2022 Financial Results
5:00pm
6-K
v65tnafspw zi1ih
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
6-K
EX-99.1
nznd2d
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
S-8
EX-5.1
grp1mb cu4yh9qjzl3d5
1 Jul 22
Registration of securities for employees
5:12pm
CORRESP
rfbxezkie22fl0l4w
1 Jul 22
Correspondence with SEC
12:00am
F-3/A
8wo33 juw
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
F-3/A
EX-23.3
yecrr6
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
6-K
98zm8yt6isuat
17 Jun 22
Current report (foreign)
4:06pm
6-K
xwavj
10 Jun 22
Current report (foreign)
6:05am
UPLOAD
2tzwfx
3 Jun 22
Letter from SEC
12:00am